The push to increase clinical trial diversity may just be a distraction from a bigger problem, US Food and Drug Administration Commissioner Robert Califf said.
Califf told the Alliance for a Stronger FDA on 12 July that the lack of health equity is the real issue that should be addressed, adding that
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?